Participant count type changed
Before: Estimated. After: Actual.
Enrollment · participant count changed
Before: 250 participants (planned). After: 253 participants (actual).
Recruitment status changed
Before: Active not recruiting. After: Completed.
Study sponsor: Avalo Therapeutics, Inc. · AVTX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: Estimated. After: Actual.
Before: 250 participants (planned). After: 253 participants (actual).
Before: Active not recruiting. After: Completed.
Before: Estimated. After: Actual.
Before: Mar 2026. After: 23 Feb 2026.